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ABSTRACT
Using a component of the Escherichia coli protein
degradation machinery, we have established a
system to regulate protein stability in mycobacteria.
A protein tag derived from the E. coli SsrA degrad-
ation signal did not affect several reporter proteins
in wild-type Mycobacterium smegmatis or
Mycobacterium tuberculosis. Expression of the
adaptor protein SspB, which recognizes this
modified tag and helps deliver tagged proteins to
the protease ClpXP, strongly decreased the
activities and protein levels of different reporters.
This inactivation did not occur when the function
of ClpX was inhibited. Using this system, we con-
structed a conditional M. smegmatis knockdown
mutant in which addition of anhydrotetracycline
(atc) caused depletion of the beta subunit of RNA
polymerase, RpoB. The impact of atc on this
mutant was dose-dependent. Very low amounts of
atc did not prevent growth but increased sensitivity
to an antibiotic that inactivates RpoB. Intermediate
amounts of RpoB knockdown resulted in bacterio-
stasis and a more substantial depletion led to a
decrease in viability by up to 99%. These studies
identify SspB-mediated proteolysis as an efficient
approach to conditionally inactivate essential
proteins in mycobacteria. They further demonstrate
that depletion of RpoB by  93% is sufficient to
cause death of M. smegmatis.
INTRODUCTION
Tuberculosis (TB) remains a global health threat and new
therapies that can shorten treatment time and cure
drug-resistant TB are urgently needed. Drug development
is stalled by the lack of good targets, including proteins
required during both active and latent disease and those
whose partial inactivation results in death of
Mycobacterium tuberculosis, the causative agent of TB.
Current approaches to the identiﬁcation and validation
of such targets include transcriptional silencing of the
gene encoding a potential drug target to determine the
vulnerability of the pathogen to target inactivation
(1–8). Although it has been successfully applied to
M. tuberculosis, transcriptional gene silencing does have
limitations. The manifestation of phenotypic conse-
quences of silencing can be slow, and stable low-
abundance proteins are difﬁcult to inactivate by this
approach. Therefore, we set out to establish a system
that directly regulates protein stability in mycobacteria.
Targeting bacterial proteins for degradation is achieved
by multiple mechanisms, including speciﬁc recognition of
N- or C-terminal degradation tags (9). One such degrad-
ation tag is encoded by ssrA, a small stable RNA that can
mediate the addition of the amino acids it encodes to the
C-terminus of a nascent polypeptide in a process called
trans-translation (10). In E. coli, SsrA-tagged proteins
can be degraded by several proteases, including Tsp,
HﬂB, ClpAP, Lon and ClpXP (10). Degradation by
ClpXP is speciﬁcally enhanced by the adaptor protein
SspB, which tethers SsrA-tagged proteins to ClpX
(11,12). ClpX and SspB recognize different amino acids
of the SsrA tag: ClpX interacts with the three C-terminal
residues, whereas SspB binds to the N-terminus (13).
SspB is not essential for degradation of SsrA-tagged
proteins by ClpXP in E. coli. However, mutating the
ClpX-binding region of SsrA weakened the interaction
between the tagged protein and ClpX. Degradation of
proteins containing such mutated tags, e.g. the so-called
DAS+4 tag, was SspB-dependent in E. coli (14,15). We
expected that this controlled proteolysis system could
also function in mycobacteria because (i) ClpX from
E. coli and mycobacteria are similar, (ii) mycobacterial
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tag differs from mycobacterial SsrA tags and thus is
unlikely to be recognized by mycobacterial proteases
and (iv) many residues of E. coli ClpX required for the
interaction with SspB are conserved in mycobacterial
ClpX proteins. In accordance with these expectations,
we found that E. coli SspB can be used to control the
stability of DAS+4-tagged proteins in Mycobacterium
smegmatis and in M. tuberculosis. We applied controlled
proteolytic inactivation to M. smegmatis RpoB, the b
subunit of the RNA polymerase (RNAP), and
demonstrated that decreasing the steady-state level of
this protein mimics the mycobactericidal activities of
rifamycins.
MATERIALS AND METHODS
Plasmids, bacterial strains, media and reagents
The bacterial strains and plasmids used in this study are
listed in Supplementary Table S1. Plasmids were con-
structed using standard procedures (details available
upon request). M. smegmatis rpoB-FLAG-DAS+4 was
constructed by single-crossover homologous recombin-
ation. Candidate clones were conﬁrmed by immunoblots
and PCR followed by sequencing. M. smegmatis mc
2155
and its derivatives were grown in Middlebrook 7H9
medium with 0.5% glycerol and 0.05% Tween 80, or
on Middlebrook 7H11 agar with 0.5% glycerol. For
M. tuberculosis, 7H9 medium was supplemented with
0.5% BSA, 0.2% dextrose and 0.085% NaCl; 7H11
agar was supplemented with 10% Middlebrook oleic
acid-albumin-dextrose-catalase (BD). Antibiotics were
added, where appropriate, at 50mg/ml hygromycin
(Calbiochem), 20mg/ml kanamycin (IBI Scientiﬁc) and
25mg/ml nourseothricin (HKI, Jena).
Anhydrotetracycline (atc) (Riedel-de Haen) was used at
100ng/ml, unless noted otherwise. Preparation and elec-
troporation of competent cells were performed as
described previously (16).
Fluorescence and luminescence assays
M. smegmatis and M. tuberculosis were transformed with
the appropriate plasmids and, from each transformation,
four to six single colonies were inoculated separately into
1ml 7H9 medium. After incubating at 37 C for 48–72h
(M. smegmatis) or 7–10 days (M. tuberculosis), bacteria
were diluted 10- to 30-fold in 1ml fresh medium.
Cultures were incubated for another 16–20h
(M. smegmatis) or 3–4 days (M. tuberculosis). For ﬂuor-
escence (GFP and RFP) measurements, cultures were
concentrated 10-fold in phosphate-buffered saline
(128mM NaCl, 8.5mM Na2HPO4, 3.5mM KCl, 1.5mM
KH2PO4, pH 7.4). 100ml of cultures were used for each
measurement. Optical densities were measured at 580nm
using a SpectraMax M2 or M5 plate reader (Molecular
Devices). Fluorescence was measured after excitation at
400nm and emission at 490nm (GFP) or after excitation
at 587nm and emission at 630nm (mCherry RFP).
Luminescence was measured with a SpectraMax L plate
reader (Molecular Devices) by injecting 10ml of decanal
(1% in ethanol, Sigma). Fluorescence and luminescence
were normalized to cell density and reported as relative
ﬂuorescence units (RFU) and relative luminescence units
(RLU). All measurements were performed at least twice.
Preparation of cell lysates
Bacteria were harvested by centrifugation and washed
with PBS with 0.1% Tween 80. Cells were resuspended
in 0.5–1ml of PBS and transferred into a screw-cap vial
containing  250ml of 0.1mm Zirconia/Silica beads
(BioSpec). Cells were broken by shaking in a Precellys
24 homogenizer (Bertin Technologies) or in a Mini Bead
Beater (BioSpec). Total lysates were obtained after
removing beads and unbroken cells by centrifugation at
14 000rpm twice for 10min at 4 C.
Immunoblot analysis
Cell lysates were mixed with sodium dodecyl sulfate (SDS)
loading buffer and incubated at 100 C for 3min. Proteins
were separated by 8% SDS-polyacrylamide gel electro-
phoresis (SDS-PAGE) and transferred to a nitrocellulose
membrane (Whatman) in an ice-cooled container with a
constant voltage of 100V in transfer buffer (192mM
glycine, 25mM Tris, 1% w/v SDS, 20% v/v methanol)
for 1h. Polyclonal rabbit antibodies against GFP and
FLAG were used at 1:5000–7500 and 1:400–1000 dilu-
tions, respectively, in Odyssey Blocking Buffer with
0.1% Tween 80. Polyclonal anti-SspB, anti-DlaT and
anti-PrcB rabbit sera were used at 1:5000–10000 dilutions.
Odyssey Infrared Imaging System (LI-COR Biosciences)
was used for detection.
CFU analysis of M. smegmatis MR-sspB
A culture of MR-sspB (OD580  1.0) was diluted into 1ml
fresh 7H9 with 0.5% glycerol, 0.05% Tween 80 and anti-
biotics in 96-deep-well blocks (Beckman) to an OD580 of
0.0005 with atc at concentrations ranging from 0 to
100ng/ml in quadruplicates. Serial dilutions were
spotted on 7H11 agar with or without 100ng/ml atc
prior to incubation (input) and after 1 and 3 days of in-
cubation with shaking. Colonies were counted 4–5 days
later. Suppressor mutants were determined from colonies
recovered on plates with 100ng/ml atc and were sub-
tracted from the total number of colonies recovered on
plates without atc.
RESULTS
Effects of SsrA tags on the activities of GFP, RFP and
LuxAB in M. smegmatis
We cloned gfp-ssrAec and gfp-DAS+4, which differ from
gfp only in their 30-ends such that the C-terminal amino
acids of GFP-ssrAec are identical to those encoded by
the E. coli ssrA RNA (AANDENYALAA) and the
C-terminal amino acids of GFP-DAS+4 are those of the
DAS+4 tag (AANDENYSENYADAS) (Supplementary
Table S2). Episomes that constitutively transcribed these
genes were transformed into M. smegmatis mc
2155 to
generate M. smegmatis gfp, M. smegmatis gfp-ssrAec and
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M. smegmatis gfp-DAS+4 exhibited strong green ﬂuores-
cence (white bars, Figure 1A). In contrast, M. smegmatis
gfp-ssrAec did not display any GFP-dependent ﬂuores-
cence, consistent with previous reports demonstrating de-
stabilization of GFP by the SsrA tag in mycobacteria
(17,18). We next cloned sspBmyc that encodes the E. coli
SspB protein but whose codon-usage was adapted to fa-
cilitate translation in mycobacteria, into an expression
vector that integrates into the attachment site of the
mycobacteriophage L5. Constitutive expression of SspB
did not affect growth of the bacteria (data not shown),
and did not alter green ﬂuorescence of M. smegmatis gfp
but reduced green ﬂuorescence of M. smegmatis
gfp-DAS+4 by 97.2%, so that it was indistinguishable
from that of M. smegmatis gfp-ssrAec (hatched bars,
Figure 1A). Immunoblot analyses demonstrated that the
lack of green ﬂuorescence measured in M. smegmatis
Figure 1. Effect of SsrA tags and E. coli SspB on GFP, RFP and luciferase (LuxAB) in M. smegmatis.( A) Relative ﬂuorescence units of
M. smegmatis gfp, M. smegmatis gfp-ssrAec and M. smegmatis gfp-DAS+4. White bars indicate strains without SspB; hatched bars indicate
strains with a constitutively expressed SspB. n/d: not determined. (B) GFP levels detected by immunoblotting in the same strains as in (A).
Dihydrolipoamide acyltransferase (DlaT) is used as a loading control. (C) Relative ﬂuorescence units of M. smegmatis rfp, M. smegmatis
rfp-ssrAec, M. smegmatis rfp-DAS+4, and six other M. smegmatis strains expressing variously tagged RFP. White bars indicate strains without
SspB; hatched bars indicate strains with a constitutively expressed SspB. n/d: not determined. (D) Relative luminescence units of M. smegmatis
luxAB, M. smegmatis luxAB-ssrAec and M. smegmatis luxAB-DAS+4. White bars indicate strains without SspB; hatched bars indicate strains with a
constitutively expressed SspB. n/d: not determined. (E) Relative luminescence units of M. smegmatis that chromosomally express luxAB,
luxAB-ssrAec and luxAB-DAS+4 with or without constitutively expressed SspB. Open bars indicate strains without SspB; hatched bars indicate
strains with a constitutively expressed SspB. n/d: not determined. (F) LuxB and SspB levels detected by immunoblotting in the same strains as (D).
DlaT is used as a loading control for each immunoblot. Data in (A,C–E) are means±SD of 10–20 replicates from two or three independent
experiments.
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gfp-DAS+4 with SspB were caused by low levels of the
respective ﬂuorescent protein (Figure 1B). For
mCherry-encoded red ﬂuorescent protein (RFP) (19), we
also evaluated additional tags, some of which had
improved SspB-dependent regulation of protein degrad-
ation in Bacillus subtilis (15). However, none of these
tags yielded better regulation of RFP activity in M.
smegmatis than the DAS+4 tag (Figure 1C).
GFP and RFP share little amino acid sequence identity
and differ in their oligomeric states but their monomers
fold into similar structures (20). To analyze the impact of
SspB on a protein functionally and structurally unrelated
to GFP and RFP, we used the heterodimeric luciferase
encoded by luxA and luxB. We mutated the 30-end of
luxB to encode the SsrA tag or the DAS+4 tag and ex-
pressed the different luxB genes in operons with luxA
using episomally replicating plasmids. Without SspB,
luminescence of M. smegmatis luxAB-ssrAec and
M. smegmatis luxAB-DAS+4 was 5.2 and 98.2%, respect-
ively, of that of M. smegmatis luxAB (white bars,
Figure 1D). Expression of SspB had little effect on lumi-
nescence of M. smegmatis luxAB-ssrAec, but decreased
luminescence of M. smegmatis luxAB-DAS+4 by 99.2%
(hatched bars, Figure 1D). In a strain that contained
luxAB-DAS+4 integrated into the M. smegmatis chromo-
some, expression of SspB reduced luminescence by 99.6%
(Figure 1E). As predicted by luminescence, no LuxB
protein was detected in M. smegmatis that expressed
LuxAB-DAS+4 and SspB by immunoblot (Figure 1F).
In summary, these data demonstrate that the DAS+4
tag is not recognized by a native M. smegmatis protease
and that structurally and functionally unrelated
DAS+4-tagged proteins can be inactivated by expression
of SspB.
Controlled inactivation of DAS+4-tagged proteins in
M. smegmatis
We next asked whether inactivation of a DAS+4-tagged
protein can be controlled by regulating expression of
SspB. For this, we cloned sspBmyc downstream of the
TetR-regulated, anhydrotetracycline (atc)-inducible
promoter Pmyc1tetO (21) in a plasmid that also contains
tetR. Green ﬂuorescence of M. smegmatis gfp-DAS+4
containing tetR and the inducible sspB was atc-dependent
(Figure 2A). Without atc, green ﬂuorescence was indistin-
guishable from that of M. smegmatis gfp-DAS+4 lacking
SspB; with atc, it was comparable to that of the strain in
which GFP-DAS+4 was inactivated by constitutive ex-
pression of SspB (Figure 2A). Similarly complete regula-
tion of SspB-dependent inactivation was measured
for RFP-DAS+4 (Figure 2B) and LuxAB-DAS+4
(Figure 2C). We also measured luminescence with differ-
ent atc concentrations for luxAB-DAS+4 (Figure 2D),
which demonstrated that increasing doses of atc caused
decreasing luminescence. Repression of luminescence
was maximal with as little as  1ng/ml atc. Taken
together, these ﬁndings demonstrate that transcriptional
regulation of sspBmyc provides an efﬁcient, atc
dose-dependent approach to depleting DAS+4-tagged
proteins in M. smegmatis.
Inactivation kinetics of GFP-DAS+4 and LuxAB-DAS+4
in M. smegmatis
To ascertain the time required for TetR-controlled SspB
to be induced and degrade DAS+4-tagged substrates, we
measured green ﬂuorescence of M. smegmatis containing
gfp-DAS+4, tetR and Pmyc1tetO-sspBmyc at different times
after addition of atc. Atc caused a time-dependent
decrease in green ﬂuorescence that reached half-maximal
repression after  8h (Figure 3A). Fluorescence remained
unchanged without atc. Correspondingly, GFP-DAS+4
protein levels decreased in a time-dependent manner
with atc and were stable without atc (Figure 3B). In
M. smegmatis containing luxAB-DAS+4, tetR and
Pmyc1tetO-sspBmyc, atc-induced repression of luminescence
reached half-maximal levels after  1h (Figure 3C).
Immunoblots conﬁrmed that the decrease in luminescence
corresponded with a decrease in LuxAB-DAS+4 and an
increase in SspB (Figure 3D). This analysis also revealed
that inactivation of LuxAB-DAS+4 reached maximal
levels at a time (2h post addition of atc) when the
level of SspB was still increasing (data not shown). As in
M. smegmatis gfp-DAS+4 (not shown), expression of SspB
did not affect growth of M. smegmatis luxAB-DAS+4
(Figure 3E). These experiments demonstrate that
SspB-dependent inactivation of DAS+4-tagged proteins
can be rapid, that it can occur at low SspB concentrations,
that the kinetics of inactivation are inﬂuenced by the
tagged protein, and that expression of SspB and degrad-
ation of a dispensable DAS+4-tagged protein do not affect
growth of M. smegmatis.
Inactivation of LuxAB-DAS+4 by SspB is inhibited by a
dominant negative ClpX mutant
ClpX is predicted to be essential for normal growth of
M. tuberculosis (22) and we expected ClpX also to be es-
sential in M. smegmatis. To test this we generated a ClpX
derivative, ClpX-K127R, in which the Walker A motif of
the ClpX ATP binding domain was mutated. This type of
ClpX mutant was dominant negative and allowed to con-
ditionally inactivate ClpX in Caulobacter crescentus,i n
which ClpX is also required for normal growth (23,24).
The inactivation of WT ClpX by ClpX derivatives with
defective Walker motifs is most likely due to titration of
WT ClpX into inactive heterooligomers consisting of WT
ClpX and the mutated ClpX (24). We cloned clpX-K127R
into an atc-inducible expression plasmid that replicates
episomally in mycobacteria. M. smegmatis transformed
with this plasmid was grown in liquid media without atc
and then spread on agar plates with and without atc. Atc
was applied on a paper disc in the center of the agar plate,
which resulted in a zone of growth inhibition surrounding
the disc (Figure 4A). Growth of M. smegmatis
clpX-K127R was normal on plates that contained an
atc-free paper disc. Next, we transformed clpX-K127R
into M. smegmatis that constitutively expressed
LuxAB-DAS+4 and SspB. Without atc this strain grew
normally and showed little luminescence. However,
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manner when the bacteria were cultivated with increasing
concentrations of atc (Figure 4B). At a concentration of
12ng/ml atc, luminescence values approached that of M.
smegmatis expressing LuxAB-DAS+4 without SspB. We
could not test the impact of higher atc concentrations on
the luminescence of strains expressing ClpX-K127R due
to the atc-induced growth defect. Over-expression of WT
ClpX did not affect growth (not shown) or luminescence
of any of the M. smegmatis strains analyzed (Figure 4B).
These data demonstrate that high level expression of a
dominant negative ClpX mutant prevents growth of M.
smegmatis and that lower expression interferes with the
SspB-mediated inactivation of a DAS+4-tagged protein.
ClpX is thus likely essential for growth of M. smegmatis
and the activity of SspB in M. smegmatis is, as in E. coli,
ClpX-dependent.
Controlled inactivation of DAS+4-tagged proteins in
M. tuberculosis
We used GFP and RFP with the DAS+4 tag and SspB
to determine if we could extend this system to
M. tuberculosis. Compared to M. tuberculosis gfp, green
ﬂuorescence of M. tuberculosis gfp-ssrAec was reduced by
98.8%, with and without SspB, and indistinguishable
from that of M. tuberculosis without GFP (Figure 5A).
In accordance with this lack of ﬂuorescence, no
GFP-ssrAec was detected by immunoblotting
(Figure 5B, lanes 3 and 4). Green ﬂuorescence of M. tu-
berculosis gfp-DAS+4 was slightly reduced compared to
that of M. tuberculosis gfp without sspB, but reduced by
94.2% with a constitutively transcribed sspB (Figure 5A).
Expression of SspB also decreased the level of
GFP-DAS+4 below that detectable in immunoblots
(Figure 5B, lanes 5 and 6). We next analyzed
M. tuberculosis containing gfp-DAS+4, tetR and the indu-
cible sspB. Green ﬂuorescence of this strain with atc varied
more than that of the corresponding M. smegmatis strain,
but decreased by an average of 86.3% in response to atc
(Figure 5C). We furthermore measured red ﬂuorescence of
M. tuberculosis strains expressing the different RFPs
analyzed in M. smegmatis (Figure 5D), and found that
the activity of each RFP without SspB and the extent of
inactivation achieved by coexpression of SspB were
similar in M. smegmatis and M. tuberculosis (Figure 5E).
Figure 2. Inducible degradation of DAS+4-tagged proteins by SspB in M. smegmatis.( A) Relative ﬂuorescence units of M. smegmatis gfp-DAS+4
without sspB, with constitutively expressed sspB, or with tetR and TetR-regulated sspB. White bars indicate strains cultured in the absence of the
inducer anhydrotetracycline (atc); hatched bars indicate those cultured in the presence of atc. (B) Relative ﬂuorescence units of M. smegmatis
rfp-DAS+4 without sspB, with constitutively expressed sspB, or with tetR and TetR-regulated sspB. Open bars indicate strains cultured in the absence
of anhydrotetracycline (atc); hatched bars indicate those cultured in the presence of atc. (C) Relative luminescence units of M. smegmatis
luxAB-DAS+4 without sspB, with constitutively expressed sspB, or with tetR and TetR-regulated sspB. White bars indicate strains cultured in
the absence of atc; hatched bars indicate those cultured in the presence of atc. (D) Relative luminescence units of M. smegmatis luxAB-DAS+4 with
tetR and TetR-regulated sspB cultured with different concentrations of atc. M. smegmatis luxAB-DAS+4 without sspB and M. smegmatis
luxAB-DAS+4 with constitutively expressed sspB cultured in the absence of atc serve as controls. Data are means ± SD of 10–20 replicates
from two or three independent experiments.
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expression of SspB allows controlling stability of
DAS+4-tagged proteins also in M. tuberculosis.
Controlled inactivation of RpoB in M. smegmatis
An important application of transcriptional gene silencing
systems is the construction of conditional knockdown
mutants (1–8). We selected rpoB, which encodes the b
subunit of RNAP, as the target to evaluate
SspB-mediated proteolysis for this application. We
altered the 30-end of rpoB in the chromosome to encode
the FLAG epitope (DYKDDDDK) followed by the
DAS+4 tag. This modiﬁcation did not affect growth,
compared to wild-type M. smegmatis (data not shown).
Several transformations of M. smegmatis rpoB-
FLAG-DAS+4 with a constitutive SspB expression
plasmid did not result in colonies even though expression
of SspB did not affect growth of M. smegmatis mc
2155.
We then constructed two derivatives of M. smegmatis
rpoB-FLAG-DAS+4, one that contained an atc-inducible
SspB expression plasmid (MR-sspB) and one that con-
tained a control vector without SspB (MR-control). We
ﬁrst checked the atc-induced growth defect on solid
media. For this we inoculated the left half of agar plates
with MR-control and the right half with MR-sspB and
Figure 3. Kinetics of GFP-DAS+4 and LuxAB-DAS+4 degradation in M. smegmatis.( A) M. smegmatis gfp-DAS+4, tetR and TetR-regulated sspB
were grown to an optical density of 0.2. Each half of the volume was then cultured without (solid line) or with (dashed line) 100ng/ml atc. Relative
ﬂuorescence units were determined at the indicated time points. M. smegmatis gfp-DAS+4 without sspB (closed circles) and with constitutively
expressed sspB (open circles) cultured in the absence of atc and measured at 0 and 24h serve as controls. (B) GFP levels detected by immunoblotting
from cultures in (A). A non-speciﬁc band recognized by the anti-GFP antibody serves as a loading control for each immunoblot. (C) Relative
luminescence units of M. smegmatis luxAB-DAS+4, tetR and TetR-regulated sspB in the absence (solid line) and presence (dashed line) of 100ng/ml
atc. LuxB used in these experiments contained an N-terminal FLAG tag for immunoblotting. (D) LuxB and SspB levels detected by immunoblotting
from cultures in (C). DlaT serves as a loading control for each immunoblot. (E) M. smegmatis luxAB-DAS+4 without sspB (left panel), with
constitutively expressed sspB (middle panel), and with tetR and TetR-regulated sspB (right panel) were inoculated to an optical density of 0.02
without (closed ﬁgures) or with 100ng/ml atc (open ﬁgures). Optical density was measured at the indicated time points. Data in (A), (C) and (E) are
means ± SD of four replicate cultures. The four replicate cultures in (A) and (C) were pooled to prepare lysates for immunoblotting.
Nucleic Acids Research,2011, Vol.39, No. 6 2215placed paper discs containing different amounts of atc in
the center. An atc concentration-dependent zone of inhib-
ition was visible only for MR-sspB and not for MR-control
(Figure 6A). As on solid media, growth of MR-control in
liquid media was not inﬂuenced by atc (Figure 6B).
Growth of MR-sspB in liquid media without atc was
similar to that of MR-control, but growth was strongly
suppressed with atc. This growth defect correlated with
a reduction in the protein level of the tagged RpoB.
After incubating MR-sspB with atc for 24h, the level of
RpoB-FLAG-DAS+4 decreased to  7% of the level
found without atc (Figure 6C). We next asked if the
growth defect of MR-sspB could be complemented with
WT RpoB. We cloned rpoB including its native promoter
region into a plasmid that integrates in the attachment site
of the phage L5 and transformed it into MR-sspB to
generate MR-sspB-comp. Growth of MR-sspB-comp was
not affected by atc on agar plates (not shown) or in liquid
culture (Figure 6B). A derivative of MR-control that also
expressed a second copy of rpoB grew normally under all
conditions tested. In summary, these experiments
demonstrated that combining DAS+4-tagging and
regulated expression of SspB provides a straightforward
approach to constructing a conditional M. smegmatis
knockdown mutant in which addition of atc inactivates
an essential protein. That the growth defect of MR-sspB
was fully complemented by a WT copy of rpoB
demonstrated that the cause of the growth defect was de-
pletion of RpoB and not, for example, the generation of
inhibitory degradation products.
Proteolytic inactivation of RpoB is bactericidal for
M. smegmatis
RpoB is the target of rifamycins, an important class of
antibiotics that includes the ﬁrst-line tuberculosis drug
rifampin (25). To determine if sensitivity of M. smegmatis
to rifampin increased in response to partial inactivation of
RpoB, we measured the growth of MR-sspB with different
rifampin and atc concentrations. We observed an increase
in activity of rifampin against MR-sspB at low atc con-
centrations on plates and in liquid culture (Figure 7A and
B). In contrast, low concentrations of atc did not change
the activity of other antibiotics, e.g. isoniazid (data not
shown). Inhibition of RNAP inhibitors by different anti-
biotics can be bacteriostatic or bactericidal (26). We there-
fore asked if depletion of RpoB is sufﬁcient to reduce
viability of M. smegmatis. For this, MR-sspB was
cultured in media containing 24 atc concentrations, and
CFUs of quadruplicates were determined after different
periods of incubation. Input was determined for each atc
concentration  15min after inoculation. Similar CFUs
were recovered from each atc concentration at this point
(Figure 7C). At day 1 and more so on day 3 post inocu-
lation, CFUs increased in cultures containing  0.18ng/ml
atc. In contrast, atc concentrations between 0.22 and
1.31ng/ml caused apparent bacteriostasis and
 1.64ng/ml atc reduced CFUs recovered from both time
points. Whereas the decrease in CFUs was minor after
1day, CFUs were reduced to below the limit of detection
( 1% of input) after 3 days. Thus, the impact of proteo-
lytically silencing RpoB on growth and survival of
M. smegmatis was atc dose-dependent and mimicked
the bactericidal activity of rifampin at high atc
concentrations.
DISCUSSION
The E. coli SsrA tag caused efﬁcient inactivation of GFP,
RFP and luciferase in M. smegmatis; and GFP and RFP
in M. tuberculosis. This is consistent with ﬁndings in
E. coli where the direct interaction of ClpX with the
three C-terminal amino acids of the SsrA tag (LAA) is
sufﬁcient to target a protein for degradation (13).
DAS+4-tagging did not alter, or only marginally altered,
the activities and steady-state levels of GFP, RFP and
LuxAB in mycobacteria in the absence of SspB.
Induction of SspB with atc rapidly decreased activities
Figure 4. Involvement of ClpX in SspB-mediated degradation of
LuxAB-DAS+4. (A) M. smegmatis luxAB-DAS+4 was transformed
with an episomally replicating plasmid that expresses ClpX-K127R
under the control of a TetR-regulated promoter. Bacteria in logarith-
mic growth were incubated at 37 C for 3 days on 7H11 agar with an
atc-free (left) or an atc-containing paper disc (right). (B) Relative lu-
minescence units of M. smegmatis luxAB-DAS+4 with constitutively
expressed sspB and either a control plasmid (closed circles),
TetR-regulated WT clpX (crossed circles) or TetR-regulated
dominant-negative clpX (open circles) were cultured with different con-
centrations of atc. M. smegmatis luxAB-DAS+4 without sspB (squares)
served as control for constitutive luciferase activity. Data are means ±
SD of four or eight replicate cultures.
2216 Nucleic Acids Research, 2011,Vol.39, No. 6and steady-state levels of the DAS+4-tagged reporters to
levels observed by constitutively expressing SspB. Little, if
any, degradation occurred without atc. Low concentra-
tions of atc ( 1ng/ml) were adequate for maximal levels
of proteolysis when analyzed with tagged luciferase, sug-
gesting that a low concentration of SspB was sufﬁcient for
inactivation.
In E. coli and B. subtilis clpX is not essential, which
allowed using clpX deletion mutants to demonstrate that
SspB-mediated degradation of tagged proteins is depend-
ent on ClpX (14,15). In contrast, clpX is predicted to be
essential in M. tuberculosis (22) and we expected it to also
be essential in M. smegmatis. A ClpX variant with a
mutated ATP binding site was dominant negative over
WT ClpX of C. crescentus and was applied to study the
consequences of inactivating ClpX in this organism
(23,24). We therefore constructed ClpX-K127R, in
which the essential lysine of the Walker A motif was
Figure 5. Effect of constitutive and TetR-regulated SspB on GFP-DAS+4 in M. tuberculosis.( A) Relative ﬂuorescence units of M. tuberculosis gfp,
M. tuberculosis gfp-ssrAec and M. tuberculosis gfp-DAS+4. White bars indicate strains without SspB; hatched bars indicate strains with a consti-
tutively expressed SspB. n/d: not determined. (B) GFP and SspB levels detected by immunoblotting in the same strains as (A). DlaT is used as a
loading control for each immunoblot. (C) Relative ﬂuorescence units of M. smegmatis gfp-DAS+4 without sspB, with constitutively expressed sspB,
or with tetR and TetR-regulated sspB. White bars indicate strains cultured in the absence of atc; hatched bars indicate those cultured in the presence
of atc. (D) Relative ﬂuorescence units of M. tuberculosis expressing untagged or variously tagged RFP, as in Figure 1C. (E) Comparison of relative
ﬂuorescence units of M. smegmatis and M. tuberculosis expressing RFP with different tags as in Figures 1C and 4D. Closed black circles indicate
strains without SspB; open red circles indicate those with constitutively expressed SspB. A linear relationship is observed between RFU of M.
smegmatis expressing a tagged RFP (x-axis) and RFU of M. tuberculosis expressing the same tagged RFP (y-axis). Data in (A), (C) and (D) are
means ± SD of 12–20 replicates from two or three independent experiments.
Nucleic Acids Research,2011, Vol.39, No. 6 2217replaced by arginine, to determine the importance of ClpX
for SspB-mediated inactivation of DAS+4-tagged proteins
in M. smegmatis. As expected, over-expression of
ClpX-K127R inhibited growth of M. smegmatis.
Induction of ClpX-K127R to levels that did not prevent
growth restored luminescence in an M. smegmatis strain
that constitutively expressed LuxAB-DAS+4 and SspB.
This strain had little LuxAB activity in the absence of
ClpX-K127R. The inactivation of DAS+4-tagged
proteins is thus ClpX-dependent and, as in E. coli, likely
mediated by the delivery of tagged proteins to ClpXP by
SspB. This interpretation is also supported by sequence
similarities between the ClpX proteins of E. coli,
M. smegmatis and M. tuberculosis. This includes 84%
identical amino acids in the 26 amino acid zinc-binding
motif of E. coli ClpX ZBD, which is required for the
Figure 6. Controlled inactivation of RpoB in M. smegmatis.
(A) M. smegmatis in which the 30-end of the chromosomal rpoB gene en-
codes a FLAG epitope and the DAS+4 tag was transformed with a
plasmid that integrates tetR and TetR-regulated sspB into the chromo-
some (MR-sspB) or a control plasmid that does not contain TetR or
SspB (MR-control). MR-control (left half) and MR-sspB (right half) in
logarithmic growth were plated on 7H11 agar with antibiotics. Atc (0.5,
5 or 50ng) was added to a sterile disc in the center of the plate. Plates
were incubated at 37 C for 2 days. (B) Top: MR-control (triangles) and
MR-sspB (circles) were inoculated to an optical density of 0.02 in media
without (closed symbols) or with (open symbols) 100ng/ml atc.
Bottom: MR-control complemented with untagged rpoB (diamonds)
and MR-sspB complemented with untagged rpoB (squares) were
inoculated to an optical density of 0.02 in media without (closed
symbols) or with (open symbols) 100ng/ml atc. Optical density was
measured at the indicated time points. (C) Left: RpoB levels detected
by immunoblotting with anti-FLAG antibody from MR-sspB cultured
with or without 100ng/ml atc for 24h. Proteasome b subunit (PrcB)
serves as a loading control. Right: two-fold dilutions of the protein
lysate from MR-sspB atc cultures were loaded in comparison to
that from MR-sspB+atc for semi-quantiﬁcation. Data in (B) are
means±SD of four replicate cultures.
Figure 7. Susceptibility of M. smegmatis MR-sspB to rifampin and atc.
(A) MR-sspB in logarithmic growth was plated on 7H11 agar contain-
ing 0, 0.05 and 0.1ng/ml atc (second to fourth plates). Clockwise from
the top, 125, 62.5 and 31.25mg of rifampin were placed on three sterile
discs on the plate. Plates were incubated at 37 C for 2–3 days.
MR-control on 7H11 agar containing no atc (ﬁrst plate) was also
incubated with rifampin as a control. (B) MR-sspB in logarithmic
growth was diluted to an optical density of 0.05 in 7H9 containing
0–0.19ng/ml atc and incubated at 37 C with shaking for 4 days.
After the pre-incubation with atc only, cultures were diluted to an
optical density of 0.05 in 7H9 with the same atc concentrations but
also containing 0–100mg/ml rifampin. Optical density was measured
after 4 days of incubation. Data are means±SD of four replicates.
(C) CFU recovered from MR-sspB after 0, 1 and 3 days in 0–100ng/ml
atc. Data are means±SD of four replicate cultures.




34, which are important for
binding SspB (28), are conserved in ClpX from
M. smegmatis and M. tuberculosis.
We applied SspB-mediated proteolysis to study RpoB
for two reasons. First, RNAP is required for bacterial
growth and targeting rpoB allowed us to test the feasibility
of using in situ DAS+4-tagging and SspB-mediated prote-
olysis to study essential genes in mycobacteria. Second,
RpoB is the target of several antibiotics, which differ in
their mechanism of RNAP inhibition and their impact on
bacterial viability. For example, the rifamycins, which are
often bactericidal (25,26,29–31), have no effect on RNAP
once it has elongated past the promoter. Instead,
rifamycins speciﬁcally interfere with an early step during
transcription initiation and prevent synthesis and
retention of RNAs that are longer than 2 or 3 nts
(25,26,32,33). Other RNAP inhibitors, like streptolydigin,
inhibit initiation, elongation and pyrophosphorolysis by
bacterial RNAP but are thought to only have bacterio-
static effects (26,34–36). These data suggest that a speciﬁc
mechanism of RNAP inhibition, which in the case of
rifamycins includes repeated cycles of abortive transcrip-
tion initiation, might be required to achieve bactericidal
activity. We were therefore interested in determining if
inactivation of RNAP by RpoB depletion was sufﬁcient
to cause death of M. smegmatis.
Addition of the DAS+4 tag to RpoB did not impair
growth of M. smegmatis without SspB. Induction of
SspB with atc decreased RpoB-DAS+4 protein levels by
 93% and prevented growth of M. smegmatis in an atc
dose-dependent manner. However, when an additional,
untagged copy of rpoB was expressed, the atc-dependent
growth inhibition no longer occurred, indicating that the
growth defect was a result of RpoB depletion. Very low
concentrations of atc (0.19ng/ml or less) did not impair
growth of the RpoB knockdown strain, but increased its
susceptibility to rifampin. This increase in rifampin
activity was moderate, because only small decreases in
the steady-state level of RpoB were tolerated before deg-
radation of RpoB by itself prevented growth. Atc concen-
trations of 10ng/ml or higher not only prevented growth
but consistently reduced CFUs demonstrating that deple-
tion of RpoB was sufﬁcient to cause death of
M. smegmatis. This strongly suggests that the speciﬁc
mechanism by which rifamycins inhibit RNAP activity is
not required to achieve killing of M. smegmatis. Instead,
any potent inhibitor of mycobacterial RNAP will likely be
mycobactericidal. The extent to which CFUs decreased
after addition of atc increased over time and reached
maximal levels days after growth had stopped. This indi-
cates that inactivation of RpoB was not immediately bac-
tericidal and suggests that secondary events induced by
the inhibition of transcription were required to cause
death. Some mechanisms by which drug-induced second-
ary effects can kill E. coli have recently been identiﬁed
(37–40). Whether these mechanisms are relevant to
killing of M. smegmatis after RpoB inactivation remains
to be determined.
In contrast to the controlled proteolytic inactivation
strategy established here, transcriptional silencing has
been used to study the function of mycobacterial genes
for some time (1–8). The main advantage of transcription-
al silencing is that it does not require mutating the
targeted protein, whereas addition of a peptide tag is
required to control protein stability. Peptide tags are,
however, routinely used to facilitate puriﬁcation and/or
detection of proteins, which suggests that many proteins
will tolerate the DAS+4-tag. An advantage of controlled
proteolysis is that it leaves the native transcriptional regu-
lation of a target unperturbed. Controlled proteolysis also
actively reduces the concentration of a target protein and
does not depend on cell division for target depletion,
which is required in the case of stable proteins after tran-
scriptional repression of the encoding gene. Neither tran-
scriptional silencing nor controlled proteolysis will be
universally successful. However, they might provide com-
plementary approaches best suited for different targets.
Transcriptional silencing generally inactivates highly ex-
pressed genes efﬁciently because, for such genes, the leaki-
ness intrinsic to regulated promoters does not prevent a
large reduction in expression of the encoded protein. In
contrast, proteolysis might be most efﬁcient for proteins
whose native steady state levels are low and thus can be
efﬁciently eliminated by proteases. Thus, regulated pro-
teolytic degradation represents a novel approach that
should facilitate the identiﬁcation and validation of
targets for tuberculosis drug development.
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